These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 12174911)
21. Lanthionine synthetase components C-like 2 increases cellular sensitivity to adriamycin by decreasing the expression of P-glycoprotein through a transcription-mediated mechanism. Park S; James CD Cancer Res; 2003 Feb; 63(3):723-7. PubMed ID: 12566319 [TBL] [Abstract][Full Text] [Related]
22. Dual inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer. Boulay A; Rudloff J; Ye J; Zumstein-Mecker S; O'Reilly T; Evans DB; Chen S; Lane HA Clin Cancer Res; 2005 Jul; 11(14):5319-28. PubMed ID: 16033851 [TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells. Singh B; Cook KR; Vincent L; Hall CS; Berry JA; Multani AS; Lucci A J Surg Res; 2008 Jun; 147(2):240-6. PubMed ID: 18498876 [TBL] [Abstract][Full Text] [Related]
24. Selection of antisense oligonucleotides for reversal of multidrug resistance in breast carcinoma cells. Gao P; Zhou GY; Lei DP; Zhang XF; Li L; Xu JW; Lin XY Cytotherapy; 2007; 9(8):795-801. PubMed ID: 17917879 [TBL] [Abstract][Full Text] [Related]
25. Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells. Chang CJ; Chiu JH; Tseng LM; Chang CH; Chien TM; Wu CW; Lui WY Eur J Clin Invest; 2006 Aug; 36(8):588-96. PubMed ID: 16893382 [TBL] [Abstract][Full Text] [Related]
26. Aspirin enhances multidrug resistance gene 1 expression in human Molt-4 T lymphoma cells. Flescher E; Rotem R; Kwon P; Azare J; Jaspers I; Cohen D Anticancer Res; 2000; 20(6B):4441-4. PubMed ID: 11205285 [TBL] [Abstract][Full Text] [Related]
27. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells. Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169 [TBL] [Abstract][Full Text] [Related]
28. Levistolide A overcomes P-glycoprotein-mediated drug resistance in human breast carcinoma cells. Chen F; Wang T; Wang J; Wang ZQ; Qian M Acta Pharmacol Sin; 2008 Apr; 29(4):458-64. PubMed ID: 18358092 [TBL] [Abstract][Full Text] [Related]
29. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells. Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673 [TBL] [Abstract][Full Text] [Related]
30. Mechanisms of resistance to ansamycin antibiotics in human breast cancer cell lines. Benchekroun MN; Schneider E; Safa AR; Townsend AJ; Sinha BK Mol Pharmacol; 1994 Oct; 46(4):677-84. PubMed ID: 7969046 [TBL] [Abstract][Full Text] [Related]
31. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5. Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135 [TBL] [Abstract][Full Text] [Related]
32. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells. Rajah TT; Du N; Drews N; Cohn R Pharmacology; 2009; 84(2):68-73. PubMed ID: 19556829 [TBL] [Abstract][Full Text] [Related]
33. Activation of bone morphogenetic protein-6 gene transcription in MCF-7 cells by estrogen. Zhang M; Yan JD; Zhang L; Wang Q; Lü SJ; Zhang J; Zhu TH Chin Med J (Engl); 2005 Oct; 118(19):1629-36. PubMed ID: 16232348 [TBL] [Abstract][Full Text] [Related]
34. In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines. Johnstone SA; Gelmon K; Mayer LD; Hancock RE; Bally MB Anticancer Drug Des; 2000 Apr; 15(2):151-60. PubMed ID: 10901303 [TBL] [Abstract][Full Text] [Related]
35. Induction of apoptosis by AN-152, a cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), in LHRH-R positive human breast cancer cells is independent of multidrug resistance-1 (MDR-1) system. Günthert AR; Gründker C; Bongertz T; Nagy A; Schally AV; Emons G Breast Cancer Res Treat; 2004 Oct; 87(3):255-64. PubMed ID: 15528968 [TBL] [Abstract][Full Text] [Related]
36. Modulation of MDR1 gene expression in multidrug resistant MCF7 cells by low concentrations of small interfering RNAs. Stierlé V; Laigle A; Jollès B Biochem Pharmacol; 2005 Nov; 70(10):1424-30. PubMed ID: 16214115 [TBL] [Abstract][Full Text] [Related]
37. Clinical relationship between MDR1 gene and gallbladder cancer. Wang BL; Zhai HY; Chen BY; Zhai SP; Yang HY; Chen XP; Zhao WT; Meng L Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):296-9. PubMed ID: 15138130 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro. Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981 [TBL] [Abstract][Full Text] [Related]
39. Effects of phytoestrogen extracts isolated from flax on estradiol production and ER/PR expression in MCF7 breast cancer cells. Richter DU; Abarzua S; Chrobak M; Scholz C; Kuhn C; Schulze S; Kupka MS; Friese K; Briese V; Piechulla B; Jeschke U Anticancer Res; 2010 May; 30(5):1695-9. PubMed ID: 20592363 [TBL] [Abstract][Full Text] [Related]
40. Effect of 17-beta-estradiol on doxorubicin cytotoxicity in human breast cancer cell culture. Toma S; Leonessa F; Coialbu T; Nicolo G; Rosso R Anticancer Res; 1989; 9(2):303-8. PubMed ID: 2751257 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]